BOT revenue up 487% to $33.8M; Sofdra prescriptions up 527%
BOT reported revenue up 487% to $33.8M, with a narrower net loss and Sofdra prescriptions up 527%, per TradingView News.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.